Lund Melanoma Study Group
1 – 10 of 236
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
An Activin Receptor-Like Kinase 1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastases
2025) In The Journal of clinical investigation(
- Contribution to journal › Article
-
Mark
Cancer cells impair monocyte-mediated T cell stimulation to evade immunity
(
- Contribution to journal › Article
-
Mark
Histopathological Diagnostic Discordance between Punch Biopsies and Final Diagnostic Excisions of Cutaneous Squamous Cell Carcinoma : Analysis of 737 Cases
(
- Contribution to journal › Article
-
Mark
When Are Single Reader Evaluations Insufficient in Teledermoscopic Assessments? : Analyses of a Retrospective Cohort Study
2025) In Telemedicine journal and e-health : the official journal of the American Telemedicine Association(
- Contribution to journal › Article
- 2024
-
Mark
Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis : a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Risk factors and diagnostic tools in the skin cancer era
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
The Vitamin D Receptor as a Prognostic Marker in Breast Cancer-A Cohort Study
(
- Contribution to journal › Article
-
Mark
Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants
(
- Contribution to journal › Article